All-trans retinoic acid (ATRA)-induced apoptosis is preceded by G1 arrest in human MCF-7 breast cancer cells
1998

Effects of All-Trans Retinoic Acid on Breast Cancer Cells

publication Evidence: moderate

Author Information

Author(s): R Mangiarotti, M Danova, R Alberici, C Pellicciari

Primary Institution: Dipartimento Biologia Animale, Centro di Studio per l'Istochimica del CNR, Pavia, Italy

Hypothesis

How does all-trans retinoic acid (ATRA) affect the cell cycle and apoptosis in MCF-7 breast cancer cells?

Conclusion

ATRA inhibits the growth of MCF-7 breast cancer cells by blocking cell proliferation and inducing apoptosis.

Supporting Evidence

  • After 10 days of ATRA treatment, only 20% of the cells were still positive for the proliferation marker Ki-67 compared to 95% in controls.
  • Starting from 3 days of treatment, apoptosis was found to occur in the MCF-7 cells.
  • Flow cytometric analysis showed a significant decrease in the frequency of S-phase cells after ATRA treatment.

Takeaway

This study shows that a substance called ATRA can stop breast cancer cells from growing and can also make them die.

Methodology

The study used flow cytometry to analyze DNA content and cell cycle-related proteins in MCF-7 cells treated with ATRA.

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication